NCT04956328View on ClinicalTrials.gov

Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

PHASE3UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

September 20, 2023

Study Completion Date

September 20, 2023

Conditions
Primary Biliary Cirrhosis
Interventions
DRUG

Obeticholic Acid Tablets

Obeticholic Acid：Once a day (QD) by mouth (PO).

DRUG

UDCA

UDCA：continue prestudy dose

DRUG

Placebo

Placebo

Trial Locations (1)

130000

RECRUITING

The first hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY